TEM
Tempus AI, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$73.76
−5.20%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.5B | 1.3B | 693.4M | 531.8M | 320.7M |
| Cost of Revenue | 536.4M | 473.9M | 312.3M | 245.6M | 190.5M |
| Gross Profit | 973.0M | 797.9M | 381.1M | 286.2M | 130.2M |
| Operating Expenses | |||||
| R&D Expense | 373.1M | 319.0M | 316.8M | 185.5M | 162.3M |
| SG&A Expense | 862.5M | 715.4M | 755.4M | 296.8M | 233.4M |
| General & Admin Expense | 231.9M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 16.3M | 16.3M | — | — | — |
| Total Operating Expenses | 1.3B | 1.1B | 1.1B | 482.3M | 395.6M |
| Cost and Expenses | 1.8B | 1.5B | 1.4B | 727.9M | 586.1M |
| Operating Income (EBIT) | (278.9M) | (252.9M) | (691.1M) | (196.1M) | (265.4M) |
| Non-Operating | |||||
| Interest Income | 16.9M | 12.6M | 11.1M | 7.6M | 3.0M |
| Interest Expense | 46.6M | 70.3M | 53.7M | 46.9M | 21.9M |
| Net Interest Income | (29.7M) | (57.6M) | (42.6M) | (39.3M) | (18.9M) |
| Other Non-Op Income/Expense | 86.3M | (43.8M) | (14.5M) | (17.7M) | (24.3M) |
| Non-Operating Income (excl Interest) | (142.0M) | (32.0M) | (43.4M) | (29.4M) | 1.8M |
| EBT (Pre-Tax Income) | (192.6M) | (296.7M) | (705.5M) | (213.8M) | (289.7M) |
| Income Tax Expense | (5.7M) | (51.7M) | 266.0K | 288.0K | 66.0K |
| Bottom Line | |||||
| Net Income | (189.3M) | (245.0M) | (705.8M) | (214.1M) | (289.8M) |
| Earnings from Cont. Ops | (186.9M) | (245.0M) | (705.8M) | (214.1M) | (289.8M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (189.3M) | (245.0M) | (746.3M) | (266.0M) | (333.9M) |
| Per Share | |||||
| Basic EPS | ($1.05) | ($1.41) | ($4.60) | ($1.73) | ($1.97) |
| Diluted EPS | ($1.06) | ($1.41) | ($4.60) | ($1.73) | ($1.97) |
| Revenue Per Share | $8.32 | $7.30 | $4.28 | $3.45 | $1.89 |
| Shares | |||||
| Basic Shares Outstanding | 181.3M | 174.3M | 162.1M | 154.2M | 169.9M |
| Diluted Shares Outstanding | 181.3M | 174.3M | 162.1M | 154.2M | 169.9M |
| Profitability Metrics | |||||
| EBITDA | (31.6M) | (118.5M) | (610.4M) | (133.3M) | (236.8M) |
| D&A | 105.3M | 102.3M | 37.2M | 33.3M | 30.4M |
| EBIT | (136.9M) | (220.8M) | (647.7M) | (166.7M) | (267.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026